MAYO CLINIC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Genetic Epidemiology of Responses to Antihypertensives
Completed
- Conditions
- HypertensionCardiovascular DiseasesHeart Diseases
- Interventions
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2013-01-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 1200
- Registration Number
- NCT00005520
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Prevalence of Asymptomatic Ventricular Dysfunction
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesHeart Failure, CongestiveHeart Failure
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT00005534
Coronary Disease Morbidity and Mortality in a Population
Completed
- Conditions
- Heart DiseasesCoronary DiseaseCardiovascular DiseasesMyocardial Infarction
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 5476
- Registration Number
- NCT00005502
- Locations
- ๐บ๐ธ
St Marys Hospital, Rochester, Minnesota, United States
๐บ๐ธRochester Methodist Hospital, Rochester, Minnesota, United States
Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)
Phase 4
Completed
- Conditions
- AlcoholismSmoking
- First Posted Date
- 2000-02-04
- Last Posted Date
- 2010-09-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 144
- Registration Number
- NCT00004551
- Locations
- ๐บ๐ธ
Department of Internal Medicine, Mayo Foundation, Rochester, Minnesota, United States
Pharmacologic Relapse Prevention for Alcoholic Smokers
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2013-10-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 195
- Registration Number
- NCT00000457
- Locations
- ๐บ๐ธ
Mayo Clinic Rochester, Rochester, Minnesota, United States
Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
Not Applicable
Terminated
- Conditions
- Diabetic Neuropathies
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 75
- Registration Number
- NCT00004407
Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
Phase 2
Completed
- Conditions
- MyocarditisGiant Cell Myocarditis
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2010-09-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT00004482
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath